---
title: "SDZNY.US (SDZNY.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/SDZNY.US/news.md"
symbol: "SDZNY.US"
name: "SDZNY.US"
parent: "https://longbridge.com/en/quote/SDZNY.US.md"
datetime: "2026-03-07T05:35:31.303Z"
locales:
  - [en](https://longbridge.com/en/quote/SDZNY.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/SDZNY.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/SDZNY.US/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/SDZNY.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/SDZNY.US/news.md)


# SDZNY.US (SDZNY.US) — Related News

### [Berenberg Says FY26 'Year for Delivery' for Sandoz; Price Target Up](https://longbridge.com/en/news/277745418.md)
*2026-03-04T08:11:43.000Z*
> Berenberg Says FY26 'Year for Delivery' for Sandoz; Price Target Up

### [Huahaipharm won the lawsuit but lost the market](https://longbridge.com/en/news/277461713.md)
*2026-03-02T12:04:59.000Z*
> Huahaipharm recently won an arbitration from the International Chamber of Commerce, ruling that it is not liable for bre

### [Assessing Sandoz Group (SWX:SDZ) Valuation After Strong 2025 Results And Biosimilar Growth Milestones](https://longbridge.com/en/news/277092790.md)
*2026-02-26T20:40:58.000Z*
> Sandoz Group (SWX:SDZ) reported strong 2025 earnings with sales of US$11,086 million and net income of US$914 million, h

### [Switzerland's Sandoz Posts Improved FY25 Net Income, Sales](https://longbridge.com/en/news/276843633.md)
*2026-02-25T06:41:11.000Z*
> Switzerland's Sandoz Posts Improved FY25 Net Income, Sales

### [Sandoz FY sales USD 11.1 bln vs IBES estimate USD 11.1 bln](https://longbridge.com/en/news/276841898.md)
*2026-02-25T06:21:52.000Z*
> Sandoz FY sales USD 11.1 bln vs IBES estimate USD 11.1 bln

### [AlphaValue/Baader Europe Lifts Sandoz Price Target, Notes Biosimilar Momentum](https://longbridge.com/en/news/276102635.md)
*2026-02-17T07:43:14.000Z*
> AlphaValue/Baader Europe Lifts Sandoz Price Target, Notes Biosimilar Momentum

### [Alvotech Signs Biosimilar Supply and Commercialization Agreements with Sandoz for Canada, Australia, and New Zealand](https://longbridge.com/en/news/274480789.md)
*2026-02-02T08:00:14.000Z*
> Alvotech SA has signed supply and commercialization agreements with Sandoz for multiple biosimilar candidates in Canada,